Mithrl raised a $20 million Series A led by Obvious Ventures to expand a biomedical “world model” and agentic workflow for accelerating R&D from idea to IND. The company says Mithrl-1 integrates curated validated biology with public and partner datasets, enabling hypothesis generation with source traceability and confidence scoring while reducing token usage versus standard workflows.